Enveric Biosciences, Inc. - SIC # 8231 - LIBRARIES

Ticker Exchange SIC # Website Latest Ticker
ENVB Nasdaq 8231 www.enveric.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Enveric Biosciences, Inc.

Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit - Jun 29th, 2026 6:00 am
Enveric Biosciences Announces Participation in 2026 BIO International Convention - Jun 16th, 2026 7:28 am
Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day - Jun 9th, 2026 6:00 am
Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003 - Jun 2nd, 2026 6:00 am
Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors - Apr 28th, 2026 5:33 am
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Feb 22nd, 2026 5:43 pm
Enveric Biosciences reports EB-003 receptor engagement assay data - Feb 20th, 2026 6:09 am
Enveric Biosciences announces issuance of U.S. patent - Dec 30th, 2025 6:10 am
AbbVie's Bretisilocin Hit With Enveric IP Claim - Oct 15th, 2025 12:48 pm
Enveric Biosciences hires Fish & Richardson to defend patent tied to AbbVie deal - Oct 15th, 2025 6:30 am